SFA
ALNY icon

Souders Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Souders Financial Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
1,769
+125
+8% +$37.7K 0.05% 142
2026
Q1 		$544K Buy
1,644
+234
+17% +$79.6K 0.06% 139
2025
Q4 		$561K Sell
1,410
-13
-0.9% -$5.75K 0.06% 126
2025
Q3 		$649K Buy
1,423
+64
+5% +$26.1K 0.08% 116
2025
Q2 		$443K Sell
1,359
-434
-24% -$120K 0.06% 140
2025
Q1 		$484K Sell
1,793
-947
-35% -$243K 0.07% 131
2024
Q4 		$645K Sell
2,740
-613
-18% -$161K 0.09% 118
2024
Q3 		$922K Sell
3,353
-159
-5% -$41.4K 0.13% 106
2024
Q2 		$853K Buy
3,512
+36
+1% +$5.68K 0.13% 102
2024
Q1 		$519K Buy
3,476
+529
+18% +$88.2K 0.08% 119
2023
Q4 		$564K Buy
2,947
+255
+9% +$43.4K 0.1% 112
2023
Q3 		$477K Buy
2,692
+39
+1% +$7.44K 0.09% 118
2023
Q2 		$504K Buy
2,653
+417
+19% +$82.7K 0.1% 117
2023
Q1 		$448K Buy
2,236
+57
+3% +$12K 0.1% 116
2022
Q4 		$518K Buy
2,179
+512
+31% +$109K 0.12% 109
2022
Q3 		$334K Buy
+1,667
New +$318K 0.09% 126

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Souders Financial Advisors's ALNY Position: Q2 2026 in Review

Souders Financial Advisors increased its Alnylam Pharmaceuticals (ALNY) stake by 7.6% in Q2 2026, buying an estimated $37.7K and bringing the position to 1,769 shares worth $533K. The position accounts for 0.05% of the portfolio, ranked #142.

Souders Financial Advisors first reported a position in ALNY in Q3 2022 and has held it in 16 quarters since. The position peaked at $922K in Q3 2024. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Souders Financial Advisors held 1,769 shares of Alnylam Pharmaceuticals worth $533K as of Q2 2026.
  • Souders Financial Advisors bought 125 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $37.7K.
  • Alnylam Pharmaceuticals made up 0.05% of Souders Financial Advisors's portfolio in Q2 2026, its #142 holding.
  • Souders Financial Advisors first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Souders Financial Advisors's Alnylam Pharmaceuticals position peaked at $922K in Q3 2024.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Souders Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.